Abbott Laboratories (ABT) Revenue — Quarter Ended Dec 31, 2025
Revenue for the quarter increased compared with both the immediately preceding quarter and the same quarter one year earlier. The sequential gain was modest, while the year-over-year rise was more pronounced.
Key takeaway
Quarter ended Dec 31, 2025 · FY2025 Q4
Revenue for the quarter increased compared with both the immediately preceding quarter and the same quarter one year earlier. The sequential gain was modest, while the year-over-year rise was more pronounced.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$11.5B
Revenue reported for this quarter.
Quarter-over-quarter
+0.8%
Change from the immediately preceding quarter.
Year-over-year
+4.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$44.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2025 | $10.4B | +4.0% |
| Jun 30, 2025 | $11.1B | +7.4% |
| Sep 30, 2025 | $11.4B | +6.9% |
| Dec 31, 2025 | $11.5B | +4.4% |
Revenue performance
Reported revenue rose from the prior quarter and from the year-ago period, reflecting continued growth. The year-over-year improvement was larger than the sequential change.
Quarterly comparison
Compared with the immediately preceding quarter, revenue increased at a modest rate. Versus the same quarter one year earlier, the gain was stronger, indicating a solid year-over-year performance.
What to watch
The sequential revenue growth rate decelerated compared to the prior quarter's pace, which may warrant attention.